TestRAMP
TestRAMP was a London-based B2B marketplace founded in 2020 that connected UK diagnostic labs with clinicians and healthcare institutions for PCR testing procurement, running a 100% philanthropic model that donated all fee income to charity. The company was retired in 2022 post-pandemic after generating £2.4 million for good causes.
- Company typePrivate
- Founded2020
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingDigital Commerce or Content
What TestRAMP does
TestRAMP was a London-based B2B marketplace, founded in 2020 by Mike Hudson, that operated as the world's first PCR testing capacity marketplace. It connected PCR test buyers — clinicians and healthcare institutions — with sellers, namely the UK's largest genetics and genomics diagnostic labs, enabling direct procurement of PCR testing services at negotiated fair market prices. Transaction fees were charged to both sides of the marketplace, and the platform additionally supported resilience through a sister service called Labsure (labsure.org), which allowed labs to sell spare capacity to each other during surge demand. The website (testramp.org) served as the primary distribution channel, with supplementary presence on Twitter and LinkedIn.
The company ran a unique 100% commercial and 100% philanthropic model: all fee income after costs and taxes was donated to charitable causes. Over its operating life, TestRAMP generated £2.4 million in gross fee income and donated over £2 million to charities including Alzheimer's Society (£500k in 2021), ZSL / Zoological Society of London (£500k in 2021), the Mike Hudson Foundation (£1M in 2022), and Pilgrims Hospices (£50k in 2022). The Mike Hudson Foundation is a donor-advised fund operating under Prism the Gift Fund (registered charity no. 1099682).
TestRAMP was retired in 2022 as the acute phase of the Covid-19 pandemic subsided. The underlying demand driver for the marketplace — emergency PCR testing capacity — collapsed with the end of the public health emergency, and the company wound down its operations, directing any remaining philanthropic activity through the Mike Hudson Foundation. The company had no disclosed institutional venture or private equity backing and was classified as a non-profit, private entity with 1–10 employees throughout its operating life.
TestRAMP firmographics
Firmographics- Name
- TestRAMP
- Legal name
- TestRAMP
- Website
- https://testramp.org
- Company type
- Private
- Founded year
- 2020
- Operating status
- Closed
- Headcount range
- 1–10 employees
- Short description
- TestRAMP was a London-based B2B marketplace founded in 2020 that connected UK diagnostic labs with clinicians and healthcare institutions for PCR testing procurement, running a 100% philanthropic model that donated all fee income to charity. The company was retired in 2022 post-pandemic after generating £2.4 million for good causes.
- Ownership category
- akta.pro rank
TestRAMP industry classification
Industry- Product category
- Diagnostic Testing Marketplace
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
Keywords
Where TestRAMP is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
TestRAMP business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Transaction/Marketplace Fees: TestRAMP charged both buyers (Clinicians/Healthcare Institutions) and sellers (Labs) transaction fees for using the marketplace platform. All fee income after costs and taxes was directed entirely to charitable causes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Marketplace transaction fees |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
TestRAMP product offering
Product offeringCore offering
TestRAMP operated the world's first PCR capacity marketplace, a B2B platform connecting PCR test buyers (clinicians and healthcare institutions) with UK diagnostic laboratories offering PCR and genetic/genomic testing services. The marketplace facilitated fair market price negotiation and enabled Labs to share capacity with each other during surge demand. The platform charged transaction fees to both buyers and sellers, with 100% of net fee income donated to charitable causes.
Product overview
TestRAMP was a single core product — a B2B PCR testing marketplace platform that connected laboratories with clinicians and healthcare institutions. The platform enabled PCR test providers to source testing services from leading UK genetics and genomics labs, negotiate fair market prices, and manage surge demand through capacity sharing. TestRAMP was retired in 2022 post-pandemic.
Differentiator
Problem solved
Functional benefit
Brands
- Labsure: A resilience platform that helps labs sell capacity to each other to manage surge demand.
Products and services
- TestRAMP Genomic Testing Marketplace A B2B PCR testing marketplace that connected PCR test providers (clinicians and healthcare institutions) with the UK's largest genetics and genomics laboratories. The platform facilitated fair market pricing negotiation and served as a centralized procurement channel for PCR testing services.
- Labsure A resilience platform that helps labs sell capacity to each other to manage surge demand for PCR testing. Part of the TestRAMP ecosystem supporting resilience in PCR testing capacity.
Quantifiable outcome
- £2.4 million generated for good causes
- +1 more outcomes
Companies that use TestRAMP
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
TestRAMP technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
TestRAMP partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- Pilgrims HospicesminorCharity dedicated to helping people facing incurable diseases. Received £50k donation from TestRAMP in 2022.
- Mike Hudson FoundationcoreMike Hudson Foundation (DAF) is a restricted fund operating under the auspices of Prism the Gift Fund, registered charity no. 1099682. Received £1 million donation in 2022 to support good causes. TestRAMP redirects all its fee income to this foundation.
- Alzheimer's SocietyminorCharitable recipient of TestRAMP donations. Received £500k donation in 2021 from TestRAMP's philanthropic fund.
- ZSL (Zoological Society of London)minorCharitable recipient of TestRAMP donations. Received £500k donation in 2021 and featured as a corporate partnership on ZSL's website.
- LabsurecoreRelated platform/service enabling Labs to sell capacity to each other for surge demand management. Labsure is part of the TestRAMP ecosystem supporting resilience in PCR testing capacity.
Scale indicators3 records
Recent moves5 records
Expansion highlights3 records
TestRAMP competitors and assessment
Company assessmentEmerging players
- 1health.io: Operates a marketplace for diagnostic and at-home testing, connecting labs with healthcare providers and consumers. Comparable to TestRAMP as a multi-sided platform facilitating test procurement and lab capacity utilization.
- Prenetics: COVID-19 PCR testing provider that scaled lab-based testing services during the pandemic. Comparable to TestRAMP's lab-side counterparties as a diagnostics operator tied to pandemic demand cycles.
- Color Health: Population-scale genetic testing and clinical genomics platform operating lab infrastructure with employer and healthcare distribution. Comparable to TestRAMP's lab-network orientation in molecular and genetic testing delivery.
- Helix: Genomics platform operating a clinical lab network for population-scale DNA testing. Comparable to TestRAMP's genomic and PCR testing lab network focus and B2B distribution model.
Broad incumbents
- Laboratory Corporation of America (Labcorp): Global clinical laboratory network offering PCR, molecular, and genetic testing services to providers and patients. Comparable to TestRAMP's lab ecosystem as a large-scale incumbent diagnostic platform.
- Quest Diagnostics: One of the largest clinical laboratory services networks in the US, including PCR and molecular diagnostics. Comparable to TestRAMP's lab counterparties as a broad incumbent in diagnostics with PCR testing capacity.
- NeoGenomics: Specialized clinical laboratory services focused on oncology and molecular diagnostics. Comparable to TestRAMP's lab counterparties as a commercial lab with PCR and molecular testing capacity serving healthcare providers.
Direct peers
- Source BioScience: UK-based provider of diagnostics, pathology, genomics, and precision medicine services; named customer and endorser of TestRAMP. Directly comparable as a UK genomic and PCR testing lab that participated in the TestRAMP marketplace.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
TestRAMP social profiles
Digital presenceTestRAMP financial estimates
Financial estimateRevenue estimate
Valuation estimate
TestRAMP leadership team
Management profileNumber of profiles
Profiles1 record
TestRAMP subsidiaries and ownership
Company hierarchySubsidiaries1 record
TestRAMP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TestRAMP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TestRAMP
What does TestRAMP do?
TestRAMP operated the world's first PCR capacity marketplace, a B2B platform connecting PCR test buyers (clinicians and healthcare institutions) with UK diagnostic laboratories offering PCR and genetic/genomic testing services. The marketplace facilitated fair market price negotiation and enabled Labs to share capacity with each other during surge demand. The platform charged transaction fees to both buyers and sellers, with 100% of net fee income donated to charitable causes.
Is TestRAMP a public or private company?
TestRAMP is a private company. It is classified as founder individual operated bootstrapped and is currently closed.
When was TestRAMP founded?
TestRAMP was founded in 2020. It employs 1 to 10 people.
Where is TestRAMP based?
TestRAMP is headquartered in London, United Kingdom, in the Europe region.
How does TestRAMP make money?
One revenue line is on record: transaction/Marketplace Fees.
Who are TestRAMP's main competitors?
Emerging players on record are 1health.io, Prenetics, Color Health and Helix. Broad incumbents are Laboratory Corporation of America (Labcorp), Quest Diagnostics and NeoGenomics. Source BioScience is listed as a direct peer.
Does TestRAMP have an API?
No public API is recorded for TestRAMP.
What industry is TestRAMP in?
TestRAMP's product category is Diagnostic Testing Marketplace. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 621511 and its SIC code is 8071.